HIV reproducibly establishes a latent infection after acute infection of T cells in vitro

EMBO Journal

Volumn 22, Issue 8, 2003, Pages 1868-1877

  Jordan, Albert ^a,c   Bisgrove, Dwayne ^a   Verdin, Eric ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

Chromatin; HIV; Latent infection; Tat; Transcriptional silencing

Indexed keywords

GREEN FLUORESCENT PROTEIN; PHORBOL ESTER; RETROVIRUS VECTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LINE; HETEROCHROMATIN; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LYMPHOCYTE CLONE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSCRIPTION INITIATION; VIRUS GENOME; VIRUS INFECTION;

CELL LINE; CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, VIRAL; GREEN FLUORESCENT PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; LUMINESCENT PROTEINS; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; VIRUS ACTIVATION; VIRUS INTEGRATION; VIRUS LATENCY;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0037446948     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdg188     Document Type: Article

References (33)

1. Antoni, B.A., Rabson, A.B., Kinter, A., Bodkin, M. and Poli, G. (1994) NF-κB-dependent and -independent pathways of HIV activation in a chronically infected T cell line. Virology, 202, 684-694.
2. Bieniasz, P.D. and Cullen, B.R. (2000) Multiple blocks to human immunodeficiency virusi type 1 replication in rodent cells. J. Virol., 74, 9868-9877.
3. Butera, S.T. (2000) Therapeutic targeting of human immunodeficiency virus type-1 latency: Current clinical realities and future scientific possibilities. Antiviral Res., 48, 143-176.
4. Butler, S.L., Hansen, M.S. and Bushman, F.D. (2001) A quantitative assay for HIV DNA integration in vivo. Nat. Med., 7, 631-634.
5. Carteau, S., Hoffmann, C. and Bushman, F. (1998) Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target. J. Virol., 72, 4005-4014.
6. Chen, W.Y., Bailey, E.C., McCune, S.L., Dong, J.Y. and Townes, T.M. (1997) Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc. Natl Acad. Sci. USA, 94, 5798-5803.
7. Choo, K.H., Vissel, B., Nagy, A., Earle, E. and Kalitsis, P. (1991) A survey of the genomic distribution of α satellite DNA on all the human chromosomes, and derivation of a new consensus sequence. Nucleic Acids Res., 19, 1179-1182.
8. Chun, T.W. and Fauci, A.S. (1999) Latent reservoirs of HIV: obstacles to the eradication of virus. Proc. Natl Acad. Sci. USA, 96, 10958-10961.
9. Chun, T.W. et al. (1997a) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature, 387, 183-188.
10. Chun, T.W., Stuyver, L., Mizell, S.B., Ehler, L.A., Mican, J.A., Baseler, M., Lloyd, A.L., Nowak, M.A. and Fauci, A.S. (1997b) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl Acad. Sci. USA, 94, 13193-13197.
11. + T cells using a combination of cytokines. J. Exp. Med., 188, 83-91.
12. + T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat. Med., 5, 651-655.
13. Emiliani, S., Van Lint, C., Fischle W., Paras, P., Jr, Ott, M., Brady, J. and Verdin, E. (1996) A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc. Natl Acad. Sci. USA, 93, 6377-6381.
14. Emiliani, S., Fischle, W., Ott, M., Van Lint, C., Amella, C.A. and Verdin, E. (1998) Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line. J. Virol., 72, 1666-1670.
15. Finzi, D. et al. (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science, 278, 1295-1300.
16. Finzi, D. et al. (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med., 5, 512-517.
17. Groudine, M., Eisenman, R. and Weintraub, H. (1981) Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation. Nature, 292, 311-317.
18. Jenuwein, T. (2001) Re-SET-ting heterochromatin by histone methyltransferases. Trends Cell Biol., 11, 266-273.
19. Jenuwein, T. and Allis, C.D. (2001) Translating the histone code. Science, 293, 1074-1080.
20. Jordan, A., Defechereux, P. and Verdin, E. (2001) The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J., 20, 1726-1738.
21. Kalpana, G.V., Marmon, S., Wang, W., Crabtree, G.R. and Goff, S.P. (1994) Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science, 266, 2002-2006.
22. Kam, J. (1999) Tackling Tat. J. Mol. Biol., 293, 235-254.
23. Miller, M.D. and Bushman, F.D. (1995) HIV integration. Inil for integration? Curr. Biol., 5, 368-370.
24. Minami, M., Poussin, K., Bréchot, C. and Paterlini, P. (1995) A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome. Genomics, 29, 403-408.
25. Pierson, T., McArthur, J. and Siliciano, R.F. (2000) Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu. Rev. Immunol., 18, 665-708.
26. Poli, G. and Fauci, A.S. (1993) Cytokine modulation of HIV expression. Semin. Immunol., 5, 165-173.
27. Schmidt, M. et al. (2001) Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum. Gene Ther., 12, 743-749.
28. Schroder, A.R., Shinn, P., Chen, H., Berry, C., Ecker, J.R. and Bushman, F. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 110, 521-529.
29. Tartof, K.D. (1994) Position effect variegation in yeast. BioEssays, 16, 713-714.
30. VanLint, C., Emiliani, S., Ott, M. and Verdin, E. (1996) Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J., 15, 1112-1120.
31. Verdin, E., Paras, P., Jr and Van Lint, C. (1993) Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J., 12, 3249-3259.
32. Wallrath, L.L. (1998) Unfolding the mysteries of heterochromatin. Curr. Opin. Genet. Dev., 8, 147-153.
33. Wong, J.K., Hezareh, M., Günthard, H.F., Havlir, D.V., Ignacio, C.C., Spina, C.A. and Richman, D.D. (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science, 278, 1291-1295.